We are live on ! Find out more
BMO

Beck Mack & Oliver Portfolio holdings

AUM $4.85B
1-Year Est. Return 9.66%
This Fund
S&P 500
This Quarter Est. Return
+10.76%
1 Year Est. Return
+9.66%
3 Year Est. Return
+69.39%
5 Year Est. Return
+96.17%
10 Year Est. Return
+350.87%
AUM
$4.93B
AUM Growth
+$634M
Cap. Flow
+$193M
Cap. Flow %
3.91%
Top 10 Hldgs %
46.72%
Holding
190
New
7
Increased
53
Reduced
59
Closed
11

Top Buys

Rank Stock Value
1
AMZN icon
Amazon
AMZN
+$17.4M
2
AJG icon
Arthur J. Gallagher & Co
AJG
+$13.1M
3
RUSHA icon
Rush Enterprises Class A
RUSHA
+$11.4M
4
CACC icon
Credit Acceptance
CACC
+$10.8M
5
OWL icon
Blue Owl Capital
OWL
+$10.2M

Top Sells

Rank Stock Value
1
TEVA icon
Teva Pharmaceuticals
TEVA
+$6.79M
2
TCN
Tricon Residential Inc.
TCN
+$6.04M
3
SHW icon
Sherwin-Williams
SHW
+$3.09M
4
AAPL icon
Apple
AAPL
+$2.49M
5
JEF icon
Jefferies Financial Group
JEF
+$1.82M

Sector Composition

Rank Sector Weight
1 Financials 40.58%
2 Healthcare 13.65%
3 Technology 12.84%
4 Industrials 7.53%
5 Communication Services 6.95%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
OTIS icon
126
Otis Worldwide
OTIS
$27.9B
$451K 0.01%
4,547
– –
USB icon
127
US Bancorp
USB
$97.9B
$438K 0.01%
9,790
-362
-4% -$15.3K
DIS icon
128
Walt Disney
DIS
$171B
$432K 0.01%
3,532
-600
-15% -$62.7K
TSLA icon
129
Tesla
TSLA
$1.18T
$410K 0.01%
2,330
– –
ELV icon
130
Elevance Health
ELV
$81.5B
$407K 0.01%
784
+313
+66% +$156K
NVS icon
131
Novartis
NVS
$302B
$406K 0.01%
4,200
– –
EOG icon
132
EOG Resources
EOG
$77.7B
$382K 0.01%
2,985
– –
BSX icon
133
Boston Scientific
BSX
$68.4B
$377K 0.01%
5,500
-500
-8% -$32.1K
ALL icon
134
Allstate
ALL
$70.6B
$370K 0.01%
2,136
– –
BMY icon
135
Bristol-Myers Squibb
BMY
$129B
$369K 0.01%
6,797
– –
GDXJ icon
136
VanEck Junior Gold Miners ETF
GDXJ
$6.86B
$349K 0.01%
+9,000
New +$311K
J icon
137
Jacobs Solutions
J
$16B
$343K 0.01%
+2,698
New +$316K
DFS
138
DELISTED
Discover Financial Services
DFS
$333K 0.01%
2,540
– –
SDY icon
139
State Street SPDR S&P Dividend ETF
SDY
$22.1B
$326K 0.01%
2,483
– –
SRE icon
140
Sempra
SRE
$58.1B
$309K 0.01%
4,300
+34
+0.8% +$2.44K
SCHV
141
Schwab US Large-Cap Value ETF
SCHV
$15.6B
$304K 0.01%
11,997
-4,572
-28% -$110K
FWONA icon
142
Liberty Media Series A
FWONA
$23.4B
$300K 0.01%
+5,109
New +$309K
ITW icon
143
Illinois Tool Works
ITW
$84.1B
$297K 0.01%
1,108
+110
+11% +$28.6K
GEHC icon
144
GE HealthCare
GEHC
$32.7B
$293K 0.01%
3,219
-8
-0.2% -$666
SO icon
145
Southern Company
SO
$108B
$280K 0.01%
3,900
– –
AB icon
146
AllianceBernstein
AB
$3.47B
$266K 0.01%
7,658
– –
MO icon
147
Altria Group
MO
$125B
$259K 0.01%
5,928
– –
VB icon
148
Vanguard Small-Cap ETF
VB
$78.9B
$258K 0.01%
1,130
-40
-3% -$8.6K
DXCM icon
149
DexCom
DXCM
$29B
$252K 0.01%
1,818
– –
KMI icon
150
Kinder Morgan
KMI
$70.9B
$251K 0.01%
13,692
-2,300
-14% -$40.2K
3 4 5
6
7

Similar funds

SCA
Southpoint Capital Advisors New York $4.86B AUM 34.09% 1-Year Est. Return
MCCA
Mill Creek Capital Advisors Conshohocken, Pennsylvania $4.87B AUM 17.69% 1-Year Est. Return
AC
Aristeia Capital Greenwich, Connecticut $4.82B AUM 24.94% 1-Year Est. Return
TPCW
TD Private Client Wealth New York $4.82B AUM 15.21% 1-Year Est. Return
DGI
Disciplined Growth Investors Minneapolis, Minnesota $4.89B AUM 33.85% 1-Year Est. Return
JSTA
Japan Science & Technology Agency Tokyo, Japan $4.81B AUM 4.62% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return
KCM
Kensico Capital Management Greenwich, Connecticut $4.9B AUM 41.26% 1-Year Est. Return

Beck Mack & Oliver's Q1 2024 Portfolio in Review

As of Q1 2024, Beck Mack & Oliver held 190 positions worth $4.93B, up 15% from $4.3B the previous quarter. Its ten largest holdings account for 47% of the portfolio.

Beck Mack & Oliver deployed $193M of net new capital in Q1 2024, opening 7 new positions and adding to 53 existing holdings. Its largest new stake was Smith Douglas Homes: 142,029 shares worth $4.22M.

By sector, the portfolio is most concentrated in Financials at 41% of assets, down from 41% a quarter earlier, followed by Healthcare and Technology.

On the sell side, the largest reduction was Teva Pharmaceuticals, an estimated $6.79M trimmed.

  • Beck Mack & Oliver's largest Q1 2024 buy was Smith Douglas Homes: 142,029 shares worth $4.22M.
  • Beck Mack & Oliver added most to Amazon in Q1 2024, an estimated $17.4M increase.
  • Beck Mack & Oliver's biggest Q1 2024 reduction was Teva Pharmaceuticals, cutting an estimated $6.79M.
  • Beck Mack & Oliver fully exited Blue Owl Capital in Q1 2024, selling an estimated $502K.
  • Beck Mack & Oliver's ten largest holdings make up 47% of its $4.93B portfolio in Q1 2024.
  • Beck Mack & Oliver opened 7 new positions and closed 11 in Q1 2024.
  • Beck Mack & Oliver's portfolio value rose 15% quarter-over-quarter to $4.93B.

Based on Beck Mack & Oliver's 13F filing for Q1 2024, filed 14 May 2024.